CBIO Q2 2018 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$337M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$69,560

Operating Income

-$12M

Net Income

-$11M

EPS (Diluted)

$-0.26

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$236M

Total Liabilities

$8M

Stockholders' Equity

$228M

Cash & Equivalents

$229M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$69,560	-$69,574	+0.0%
Operating Income	-$12M	-$8M	-47.4%
Net Income	-$11M	-$8M	-38.5%